Revolution Medicines to Report Financial Results for Third Quarter 2023 After Market Close on November 6, 2023

Rhea-AI Summary

Revolution Medicines, Inc. will report financial results for the third quarter 2023 on November 6, 2023, after market close. The senior management team will host a webcast to discuss the financial results and provide an update on corporate progress. A replay will be available on the company's website for at least 14 days.

REDWOOD CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers, today announced that it will report financial results for the third quarter 2023 on Monday, November 6, 2023, after market close. At 4:30 p.m. Eastern Time that day (1:30 p.m. Pacific Time), Revolution Medicines’ senior management team will host a webcast to discuss the financial results for the quarter and provide an update on corporate progress.

To listen to the live webcast, or access the archived webcast, please visit: https://ir.revmed.com/events-and-presentations. Following the live webcast, a replay will be available on the company’s website for at least 14 days.

About Revolution Medicines, Inc.
Revolution Medicines is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. The company’s RAS(ON) Inhibitors RMC-6236 (RAS^MULTI), RMC-6291 (KRAS^G12C) and RMC-9805 (KRAS^G12D) are currently in clinical development. Additional RAS(ON) Inhibitors in the company’s pipeline include RMC-5127 (KRAS^G12V), RMC-0708 (KRAS^Q61H) and RMC-8839 (KRAS^G13C) which are currently in IND-enabling development, and additional compounds targeting other RAS variants.

FAQ

When will Revolution Medicines, Inc. report its financial results for the third quarter 2023?

Revolution Medicines, Inc. will report its financial results for the third quarter 2023 on November 6, 2023, after market close.

What will be discussed during the webcast hosted by Revolution Medicines, Inc.'s senior management team?

During the webcast, Revolution Medicines, Inc.'s senior management team will discuss the financial results for the quarter and provide an update on corporate progress.

Where can I access the live webcast and the archived webcast of Revolution Medicines, Inc.'s financial results?

You can access the live webcast and the archived webcast of Revolution Medicines, Inc.'s financial results on the company's website: https://ir.revmed.com/events-and-presentations.

How long will the replay of the webcast be available?

The replay of the webcast will be available on Revolution Medicines, Inc.'s website for at least 14 days.